Ifrah Financial Services’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-18,095
| Closed | -$508K | – | 222 |
|
|
2026
Q1 | $508K | Sell |
18,095
-523
| -3% | -$13.9K | 0.13% | 106 |
|
|
2025
Q4 | $464K | Sell |
18,618
-224
| -1% | -$5.65K | 0.12% | 114 |
|
|
2025
Q3 | $480K | Buy |
18,842
+126
| +0.7% | +$3.11K | 0.12% | 116 |
|
|
2025
Q2 | $454K | Buy |
18,716
+241
| +1% | +$5.62K | 0.12% | 122 |
|
|
2025
Q1 | $468K | Sell |
18,475
-184
| -1% | -$4.82K | 0.13% | 109 |
|
|
2024
Q4 | $495K | Buy |
18,659
+321
| +2% | +$8.71K | 0.14% | 105 |
|
|
2024
Q3 | $531K | Buy |
18,338
+772
| +4% | +$22.5K | 0.14% | 106 |
|
|
2024
Q2 | $491K | Sell |
17,566
-756
| -4% | -$20.8K | 0.14% | 110 |
|
|
2024
Q1 | $508K | Buy |
18,322
+53
| +0.3% | +$1.47K | 0.14% | 109 |
|
|
2023
Q4 | $526K | Sell |
18,269
-984
| -5% | -$29.7K | 0.15% | 104 |
|
|
2023
Q3 | $639K | Buy |
19,253
+5
| +0% | +$177 | 0.2% | 87 |
|
|
2023
Q2 | $706K | Buy |
19,248
+78
| +0.4% | +$3.04K | 0.21% | 82 |
|
|
2023
Q1 | $782K | Sell |
19,170
-269
| -1% | -$11.6K | 0.25% | 75 |
|
|
2022
Q4 | $996K | Sell |
19,439
-383
| -2% | -$18.4K | 0.33% | 60 |
|
|
2022
Q3 | $867K | Sell |
19,822
-164
| -0.8% | -$7.97K | 0.3% | 68 |
|
|
2022
Q2 | $1.05M | Sell |
19,986
-382
| -2% | -$19.5K | 0.34% | 59 |
|
|
2022
Q1 | $1.05M | Sell |
20,368
-1,559
| -7% | -$80.9K | 0.3% | 67 |
|
|
2021
Q4 | $1.29M | Sell |
21,927
-46
| -0.2% | -$2.28K | 0.35% | 63 |
|
|
2021
Q3 | $945K | Buy |
21,973
+1
| +0% | +$44 | 0.27% | 74 |
|
|
2021
Q2 | $860K | Sell |
21,972
-89
| -0.4% | -$3.46K | 0.25% | 74 |
|
|
2021
Q1 | $799K | Sell |
22,061
-919
| -4% | -$32.6K | 0.24% | 77 |
|
|
2020
Q4 | $846K | Sell |
22,980
-1,535
| -6% | -$56.3K | 0.27% | 69 |
|
|
2020
Q3 | $854K | Sell |
24,515
-323
| -1% | -$11.3K | 0.31% | 65 |
|
|
2020
Q2 | $771K | Sell |
24,838
-637
| -3% | -$21.6K | 0.28% | 70 |
|
|
2020
Q1 | $789K | Sell |
25,475
-4,439
| -15% | -$151K | 0.33% | 62 |
|
|
2019
Q4 | $1.11M | Sell |
29,914
-347
| -1% | -$12.4K | 0.39% | 54 |
|
|
2019
Q3 | $1.03M | Sell |
30,261
-515
| -2% | -$18.7K | 0.38% | 60 |
|
|
2019
Q2 | $1.26M | Sell |
30,776
-453
| -1% | -$18K | 0.47% | 52 |
|
|
2019
Q1 | $1.26M | Sell |
31,229
-234
| -0.7% | -$9.37K | 0.48% | 52 |
|
|
2018
Q4 | $1.3M | Buy |
31,463
+1,995
| +7% | +$82.8K | 0.55% | 48 |
|
|
2018
Q3 | $1.23M | Sell |
29,468
-563
| -2% | -$21.7K | 0.44% | 52 |
|
|
2018
Q2 | $1.03M | Buy |
30,031
+215
| +0.7% | +$7.35K | 0.37% | 57 |
|
|
2018
Q1 | $1M | Buy |
29,816
+2,944
| +11% | +$101K | 0.37% | 56 |
|
|
2017
Q4 | $923K | Buy |
26,872
+2,747
| +11% | +$93.7K | 0.33% | 61 |
|
|
2017
Q3 | $817K | Buy |
+24,125
| New | +$775K | 0.31% | 60 |
|
|
2016
Q3 | – | Sell |
-8,414
| Closed | -$281K | – | 215 |
|
|
2016
Q2 | $281K | Sell |
8,414
-747
| -8% | -$23.8K | 0.11% | 144 |
|
|
2016
Q1 | $258K | Sell |
9,161
-35
| -0.4% | -$1K | 0.1% | 152 |
|
|
2015
Q4 | $282K | Sell |
9,196
-17
| -0.2% | -$535 | 0.11% | 140 |
|
|
2015
Q3 | $275K | Sell |
9,213
-129
| -1% | -$4.14K | 0.11% | 142 |
|
|
2015
Q2 | $297K | Buy |
9,342
+64
| +0.7% | +$2.09K | 0.11% | 140 |
|
|
2015
Q1 | $306K | Sell |
9,278
-261
| -3% | -$8.3K | 0.11% | 139 |
|
|
2014
Q4 | $282K | Sell |
9,539
-240
| -2% | -$6.88K | 0.11% | 144 |
|
|
2014
Q3 | $274K | Sell |
9,779
-5,685
| -37% | -$160K | 0.11% | 149 |
|
|
2014
Q2 | $435K | Sell |
15,464
-758
| -5% | -$21.6K | 0.16% | 111 |
|
|
2014
Q1 | $494K | Sell |
16,222
-366
| -2% | -$10.9K | 0.19% | 95 |
|
|
2013
Q4 | $482K | Sell |
16,588
-153
| -0.9% | -$4.45K | 0.19% | 97 |
|
|
2013
Q3 | $456K | Sell |
16,741
-166
| -1% | -$4.52K | 0.22% | 80 |
|
|
2013
Q2 | $449K | Buy |
+16,907
| New | +$467K | 0.23% | 76 |
|
Other funds holding PFE
AIM
SLAM
CWP
Ifrah Financial Services's PFE Position: Q2 2026 in Review
Ifrah Financial Services sold out of Pfizer (PFE) in Q2 2026, closing a stake of 18,095 shares — an estimated $508K sold.
Ifrah Financial Services first reported a position in PFE in Q2 2013 and held it in 48 quarters. The position peaked at $1.3M in Q4 2018. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Ifrah Financial Services reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
- Ifrah Financial Services sold 18,095 Pfizer shares in Q2 2026, an estimated $508K.
- Ifrah Financial Services first reported a position in Pfizer in Q2 2013 and held it in 48 quarters.
- Ifrah Financial Services's Pfizer position peaked at $1.3M in Q4 2018.
- 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Ifrah Financial Services's 13F filing for Q2 2026, filed 21 Jul 2026.